ANTONELLI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 34.302
AS - Asia 15.598
EU - Europa 11.731
SA - Sud America 2.634
AF - Africa 451
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 13
Totale 64.755
Nazione #
US - Stati Uniti d'America 33.418
SG - Singapore 4.704
IT - Italia 4.454
CN - Cina 4.383
HK - Hong Kong 2.715
BR - Brasile 2.210
SE - Svezia 1.765
VN - Vietnam 1.460
BG - Bulgaria 1.060
DE - Germania 882
FI - Finlandia 739
CA - Canada 671
TR - Turchia 623
FR - Francia 577
GB - Regno Unito 565
RU - Federazione Russa 562
UA - Ucraina 400
KR - Corea 361
IN - India 299
JP - Giappone 191
AR - Argentina 155
BD - Bangladesh 152
CH - Svizzera 146
IQ - Iraq 140
NL - Olanda 125
MX - Messico 100
CI - Costa d'Avorio 96
PL - Polonia 76
ES - Italia 75
ID - Indonesia 75
PK - Pakistan 68
EC - Ecuador 67
ZA - Sudafrica 66
AT - Austria 65
SN - Senegal 59
SA - Arabia Saudita 55
BE - Belgio 50
CO - Colombia 50
VE - Venezuela 50
UZ - Uzbekistan 49
MA - Marocco 48
PH - Filippine 39
NG - Nigeria 37
PY - Paraguay 35
KE - Kenya 32
JO - Giordania 31
IE - Irlanda 26
CZ - Repubblica Ceca 25
TN - Tunisia 25
AE - Emirati Arabi Uniti 24
IL - Israele 24
MY - Malesia 23
AU - Australia 22
JM - Giamaica 21
NP - Nepal 21
EG - Egitto 20
UY - Uruguay 20
GR - Grecia 19
IR - Iran 19
LT - Lituania 19
TH - Thailandia 19
CL - Cile 18
DZ - Algeria 18
PE - Perù 18
RO - Romania 17
BJ - Benin 16
KZ - Kazakistan 16
AL - Albania 15
OM - Oman 14
TT - Trinidad e Tobago 14
DO - Repubblica Dominicana 13
GT - Guatemala 11
HU - Ungheria 11
LB - Libano 11
PA - Panama 10
RS - Serbia 10
DK - Danimarca 9
ET - Etiopia 9
GE - Georgia 9
TW - Taiwan 9
AZ - Azerbaigian 8
HN - Honduras 8
NI - Nicaragua 8
BB - Barbados 7
BH - Bahrain 7
BO - Bolivia 7
CR - Costa Rica 7
EU - Europa 7
AM - Armenia 6
BY - Bielorussia 6
PS - Palestinian Territory 6
KG - Kirghizistan 5
KW - Kuwait 5
PT - Portogallo 5
QA - Qatar 5
AO - Angola 4
BN - Brunei Darussalam 4
GD - Grenada 4
GY - Guiana 4
LV - Lettonia 4
Totale 64.672
Città #
Ashburn 3.406
Fairfield 3.248
Woodbridge 3.131
Singapore 2.703
Hong Kong 2.688
Houston 2.062
Ann Arbor 1.952
Dallas 1.803
San Jose 1.729
Chandler 1.700
Santa Clara 1.441
Serra 1.439
Seattle 1.434
Wilmington 1.170
Cambridge 1.118
Sofia 1.056
Shanghai 957
Beijing 900
Milan 897
New York 709
Boardman 520
Ottawa 511
Hefei 499
Princeton 496
Jacksonville 477
Lawrence 424
Los Angeles 393
Council Bluffs 391
Medford 391
Lauterbourg 368
Seoul 356
Pisa 352
Helsinki 337
Ho Chi Minh City 328
Nanjing 327
Izmir 324
Des Moines 289
Dong Ket 222
Hanoi 207
Istanbul 200
Columbus 192
San Diego 180
Buffalo 177
Tokyo 175
Munich 174
São Paulo 171
The Dalles 168
Dearborn 165
Redondo Beach 161
London 155
Frankfurt am Main 144
Rome 142
Florence 141
Bern 124
Nanchang 108
Abidjan 96
Boulder 90
Jüchen 83
Redwood City 80
Kunming 76
Falls Church 74
Rio de Janeiro 73
Ogden 70
Changsha 64
Bremen 63
Shenyang 62
Dakar 59
Chicago 57
Norwalk 57
Da Nang 55
Hebei 54
Turku 54
Nuremberg 53
Pune 51
Brussels 49
Phoenix 49
Fuzhou 48
Paris 48
Warsaw 48
Washington 47
Baghdad 44
Belo Horizonte 44
Tashkent 44
Jiaxing 43
Tianjin 43
San Francisco 42
Orem 41
Haiphong 38
Lancaster 38
Brooklyn 37
Guangzhou 37
Johannesburg 37
Vienna 37
Dhaka 36
Montreal 36
Amsterdam 35
Brasília 35
Jakarta 34
Toronto 33
Atlanta 32
Totale 47.658
Nome #
A new class of tyrosine kinase inhibitors, “pyrazolo[3,4-d]pyrimidinic”compounds, has antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer 374
Autoimmune thyroid disorders 302
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 254
Subclinical hyperthyroidism and cardiovascular manifestations: a reevaluation of the association 251
Hepatitis C Virus Infection: Evidence for an Association With Type 2 Diabetes: Response to Skowronski et al. 247
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 247
Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy 243
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 237
Effect of the antileukemic agent L-asparaginase on thyroxine-binding globulin and albumin synthesis in cultured human hepatoma (HEP G2) cells. 231
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. 230
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2. 228
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 227
Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. 227
Sorafenib in the treatment of thyroid cancer 226
Unsuspected parathyroid cysts diagnosed by measurement of thyroglobulin and parathyroid hormone concentrations in fluid aspirates. 225
Molecular testing in the diagnosis of differentiated thyroid carcinomas 225
Aggressive thyroid cancer: targeted therapy with sorafenib 224
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia 217
Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors 216
Sunitinib in the treatment of thyroid cancer 215
High-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy. 213
Demeclocycline-induced phosphate diabetes in a patient with inappropriate ADH secretion and systemic sarcoidosis. 213
Comparison between ethanol sclerotherapy and emptying with injection of saline in treatment of thyroid cysts. 212
Chromosome aberrations in lymphocytes and clastogenic factors in plasma detected in Belarus children 10 years after Chernobyl accident. 212
Sorafenib and Thyroid Cancer 211
3,5-diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats 210
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 209
Age related cardiovascular dysfunction and effects of physical activity 209
B-cells and mixed cryoglobulinemia. 208
Clinical picture of endemic cretinism in central Apennines (Montefeltro). 207
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts 207
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 205
Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature 205
The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases 205
Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy. 202
Studio audiologico e dello sviluppo neuropsichico in un campione di scolari di un'area a basso apporto iodico dell'Appennino Centrale con cretinismo endemico [Audiological and neuropsychological development study in a sample of school children from a low-iodine area of the Central Apennines that is endemic for cretinism] 201
Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study 200
Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. 199
Non-cancer atherosclerotic effects associated with environmental and therapeutic radiation doses: The Chernobyl thyroid cancer children study. 199
The Italian Consensus for the Classification and Reporting of Thyroid Cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution 199
Somatostatin effect in postprandial hypoglycemia. 198
TSH Normalization in Bariatric Surgery Patients After the Switch from l-Thyroxine in Tablet to an Oral Liquid Formulation 198
Teprotumumab for Thyroid-Associated Ophthalmopathy 198
Effect of salmon calcitonin on symptoms and urinary excretion of 5 hydroxyindoleacetic acid in the carcinoid syndrome. 196
The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients 196
Risk of thyroid nodules in subjects occupationally exposed to radiation: a cross sectional study. 195
Selective use of vandetanib in the treatment of thyroid cancer 194
HCV-related autoimmune and neoplastic disorders: the HCV syndrome 193
Cancer stem cells: perspectives of new therapeutical approaches for breast cancer 193
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 193
Gastrointestinal Malabsorption of Thyroxine 192
Endemia gozzigena e patologia neuropsichica: importanza dell'apporto iodico e della funzione tiroidea sullo sviluppo del sistema nervoso centrale 191
Increased CXCL9 Serum Levels in Hepatitis C-Related Mixed Cryoglobulinemia, with Autoimmune Thyroiditis, Associated with High Levels of CXCL10 191
THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors 191
Spontaneous and bleomycin-induced chromosome damage in non cancer thyroid patients 190
Cabozantinib in Thyroid Cancer 190
Immunohistochemical study of calcitonin and somatastatin containing C cells in thyroid infiltrative diseases (Lymphoma, Hashimoto's thyroiditis, Graves' disease) 189
Is occupationally induced exposure to radiation a risk factor of thyroid nodule formation? 189
Novel therapies for thyroid autoimmune diseases: An update 189
Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy 189
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer 189
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 188
Body composition and cardiac dimensions in elite rhythmic gymnasts 188
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer 188
Completion total thyroidectomy in children with thyroid cancer secondary to the Chernobyl accident 188
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture 187
Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone 187
Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied 187
New insight in endocrine-related adverse events associated to immune checkpoint blockade 187
Thyroid disorders induced by checkpoint inhibitors 185
Findings from high resolution computed tomography of the lung and pleura of symptom free workers exposed to amosite who had normal chest radiographs and pulmonary function tests. 184
Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ 184
DICER1 Syndrome: A Multicenter Surgical Experience and Systematic Review 183
Pulmonary function, smoking habits, and high resolution computed tomography (HRCT) early abnormalities of lung and pleural fibrosis in shipyard workers exposed to asbestos. 183
3,5-diiodo-l-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet. 183
Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide 183
The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition 183
Insulin: new roles for an ancient hormone 183
CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes 182
HCV infection: pathogenesis, clinical manifestations and therapy 181
An iodine deficient area with endemic cretinism in the central appennines: studies of neuropsychological development in schoolchildren 179
Cytokines and HCV-Related Disorders. 179
Cytogenetic damage in lymphocytes of healthy and thyroid tumor-affected children from the Gomel region (Belarus). 179
Cytokines and HCV-related autoimmune disorders 178
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine 177
Increased incidence of autoimmune thyroid disorders in patients with psoriatic arthritis: a longitudinal follow-up study 177
Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients 176
Genotoxicity Evaluation of the Soybean Isoflavone Genistein in Human Papillary Thyroid Cancer Cells. Study of Its Potential Use in Thyroid Cancer Therapy 176
RET TKI: Potential Role in Thyroid Cancers 175
An iron regulatory gene signature in breast cancer: More than a prognostic genetic profile? 174
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer. 174
Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells 174
Sviluppo somatico e neuropsichico in un'area a basso apporto iodico della Toscana Settentrionale 173
Changes in autonomic regulation and ventricular repolarization induced by subclinical hyperthyroidism 173
Funzione tiroidea e sviluppo somatico della popolazione scolare di alcuni centri della Lunigiama con basso apporto iodico 172
Analysis of chromosome damage in circulating lymphocytes of radiological workers affected by thyroid nodules 172
Novel treatments for anaplastic thyroid carcinoma 172
Calcitonin, as SMS 201-995, ameliorates the VIPoma syndrome. 171
Thalidomide for improving cutaneous and pulmonary sarcoidosis in patients resistant or with contraindications to corticosteroids. 171
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C 170
Totale 20.022
Categoria #
all - tutte 188.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 188.676


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021637 0 0 0 0 0 0 0 0 0 0 0 637
2021/20224.897 92 232 151 347 829 687 126 299 248 223 290 1.373
2022/20234.790 720 573 288 439 528 682 77 353 711 23 329 67
2023/20243.937 449 436 517 279 583 704 177 135 73 63 118 403
2024/202513.265 249 536 206 779 1.116 1.454 1.065 783 1.307 1.732 1.510 2.528
2025/202615.961 1.154 2.034 2.155 1.352 1.294 1.491 2.391 721 874 1.530 506 459
Totale 66.224